Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes

Autor: Thomas Ramsey, Tanya R. Gure, Lewis E. Kazis, Daniel E. Weiner, James R. Powell, Dan R. Berlowitz, Peter M. Fitzpatrick, Debra L. Simmons, Molly B. Conroy, Donald E. Morisky, Jill C. Newman, Suzanne Oparil, Joni K. Snyder, Paul L. Kimmel, Linda P. Bolin, Capri G. Foy, Christine M. Olney, Kent Kirchner, Mark A. Supiano, Jeff Whittle, Nicholas M. Pajewski
Rok vydání: 2017
Předmět:
Zdroj: New England Journal of Medicine. 377:733-744
ISSN: 1533-4406
0028-4793
DOI: 10.1056/nejmoa1611179
Popis: BackgroundThe previously published results of the Systolic Blood Pressure Intervention Trial showed that among participants with hypertension and an increased cardiovascular risk, but without diabetes, the rates of cardiovascular events were lower among those who were assigned to a target systolic blood pressure of less than 120 mm Hg (intensive treatment) than among those who were assigned to a target of less than 140 mm Hg (standard treatment). Whether such intensive treatment affected patient-reported outcomes was uncertain; those results from the trial are reported here. MethodsWe randomly assigned 9361 participants with hypertension to a systolic blood-pressure target of less than 120 mm Hg or a target of less than 140 mm Hg. Patient-reported outcome measures included the scores on the Physical Component Summary (PCS) and Mental Component Summary (MCS) of the Veterans RAND 12-Item Health Survey, the Patient Health Questionnaire 9-item depression scale (PHQ-9), patient-reported satisfaction with their...
Databáze: OpenAIRE